Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.

Girnita A, Zheng H, Grönberg A, Girnita L, Ståhle M

DOI: 10.1038/onc.2011.239
Published: 2012 Jan 19
Container: Oncogene
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/onc.2011.239,
  title = {Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.},
  author = {Girnita A and Zheng H and Grönberg A and Girnita L and Ståhle M},
  year = {2012},
  journal = {Oncogene},
  doi = {10.1038/onc.2011.239},
  url = {https://doi.org/10.1038/onc.2011.239}
}

RIS

TY  - JOUR
TI  - Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.
AU  - Girnita A
AU  - Zheng H
AU  - Grönberg A
AU  - Girnita L
AU  - Ståhle M
PY  - 2012
JO  - Oncogene
DO  - 10.1038/onc.2011.239
UR  - https://doi.org/10.1038/onc.2011.239
ER  -

APA

A, G., H, Z., A, G., L, G., & M, S. (2012). Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.. Oncogene. https://doi.org/10.1038/onc.2011.239

Source records

pubmed · retrieved 2026-09-24T21:40:18.801Z